Related Experiment Video
Updated: Aug 12, 2026
14:03
Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
Published on: July 24, 2011
Transduction of human islets with the lentiviral vector
N Kobayashi1, T Arata, T Okitsu
1Department of Surgery, Okayama University Medical School, Okayama, Japan. immortal@md.okayama-u.ac.jp
Transplantation Proceedings
|November 3, 2004
Summary
Lentiviral gene delivery effectively introduced genes into human pancreatic islets cultured as monolayers. This advancement is crucial for developing new diabetes cell therapies.
Area of Science:
- Biotechnology
- Cell Biology
- Gene Therapy
Background:
- Efficient gene delivery to human pancreatic beta cells is vital for diabetes cell therapies.
- Lentiviral vectors are effective gene transfer tools for various cell types.
Purpose of the Study:
- To evaluate lentivirus-mediated gene delivery efficiency in human islets.
- To establish a gene delivery system for diabetes-targeted cell therapies.
Main Methods:
- Human islets were isolated, cryopreserved, and cultured as monolayers on 804G extracellular matrices.
- A vesicular stomatitis virus G-protein (VSV-G)-pseudotyped lentiviral vector (LtV-NLS/LacZ) was produced.
- Gene expression was detected using X-gal staining.
Main Results:
- Lentiviral transduction demonstrated effectiveness in human islet monolayers.
- Successful gene delivery was confirmed via NLS/LacZ expression.
Conclusions:
- Lentiviral gene delivery is a viable method for human islets.
- This technique supports the development of novel diabetes cell therapies.
